Patents by Inventor Kenneth LeClair

Kenneth LeClair has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heat shock protein binding fragments of CD91, and uses thereof
    Publication number: 20070003555
    Abstract: The present invention relates to compositions and methods for the use of natural and recombinant p95 forms and fragments as heat shock protein binding proteins. The invention is based, in part, on the Applicant's discovery that a p95 can be recombinantly expressed. The present invention also relates to CD91 polypeptide fragments that comprise at least p95 and additional contiguous sequence from domain II, III, and IV of CD91.
    Type: Application
    Filed: October 7, 2003
    Publication date: January 4, 2007
    Applicants: UNIVERSITY OF CONNECTICUT HEALTH CENTER, ANTIGENICS, INC.
    Inventor: Kenneth LeClair
  • Isolated and purified nonpeptide antigens from mycobacterium tuberculosis
    Publication number: 20020044951
    Abstract: Nonpeptide antigens were isolated and purified from Mycobacterium tuberculosis. The antigens were used in vaccine compositions, pharmaceutical compositions and methods to elicit an immune response to Mycobacterium tuberculosis in a mammal.
    Type: Application
    Filed: April 4, 2001
    Publication date: April 18, 2002
    Inventors: Gui Liu, Gerald Beltz, Kenneth LeClair, Daniel Cox, Charlotte Kensil